摘要
目的：评价根治术前化疗栓塞及术后免疫治疗巨大肾癌的疗效。方法：回顾性分析20例经术后病理检查证实并获随访的巨大肾癌患者的临床资料。分为A、B两组。术前化疗栓塞而术后免疫治疗组12例（A组），单纯根治术组8例（B组）。结果：A组术中出血量150～400ml，平均210ml。少于B组。A组1、3年生存率分别为90．0％、80．0％。B组1、3年生存率分别为66．7％、50．0％。两组比较，差别均有统计学意义（P〈O．05）。结论：根治术前化疗栓塞及术后免疫治疗安全有效，是影响巨大肾癌预后的因素。对巨大肾癌的治疗及预后有积极意义。
Objective：To study the effect of preoperative chemo embolization and postoperative usage of α-interferon in the treatment of renal cell carcinoma. Methods： The clinical data of 20 cases with large renal cell carcinoma（〉10 cm） were analyzed retrospectively. A group were treated by preoperative chemo embolization and postoperative usage of a-interferon, B group with radical nephrectomy alone. Results： The bleeding volume of A group （ 150 - 400 ml） were less than that of the control group, the 1 year （90.0 % ） and the 3 year （80.0 % ） survival rate in patients of the study group were higher than that of the control group （ P 〈0. 05）. Conclusions： Preoperative chemo-embolization and postoperative usage of a interferon is an effective means in treatment of large renal cell carcinoma and has better prognosis.
出处
《临床泌尿外科杂志》
2007年第3期207-209,共3页
Journal of Clinical Urology
关键词
肾肿瘤
化学栓塞
肾癌根治术
干扰素
Renal carcinoma
Chemo-embolization
Radical nephrectomy
Interferon
